Loading...
Thumbnail Image
Publication

Lung cancer screening in the Philippines: the need for guidelines based on the local context and the imperative for improved access to screening

Suanes, Patricia N
Alberto, Nicole Rose I
Alberto, Isabelle Rose I
Swami, Nishwant
Eala, Michelle Ann B
Tangco, Enrico D
Dee, Edward Christopher
Embargo Expiration Date
Abstract

Cancer is the second leading cause of mortality in the Philippines, a lower-middle-income country (LMIC) in Southeast Asia with a population of more than 110 million people. Lung cancer tops the list for cancer-attributable mortality in the nation. Of the world's 1.3 billion people who smoke, eighty percent come from LMICs such as the Philippines. Almost a quarter of Filipinos aged 15 years and older smoke tobacco, placing millions of people at significant risk for developing lung cancer. Despite the burden of disease attributable to lung cancer and the prevalence of risk factors such as smoking, no context-specific national screening guidelines and nationwide screening programs currently exist in the Philippines.

Source

Suanes PN, Alberto NRI, Alberto IRI, Swami N, Eala MAB, Tangco ED, Dee EC. Lung cancer screening in the Philippines: the need for guidelines based on the local context and the imperative for improved access to screening. Lancet Reg Health West Pac. 2023 Feb 16;32:100704. doi: 10.1016/j.lanwpc.2023.100704. PMID: 36866270; PMCID: PMC9971506.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.lanwpc.2023.100704
PubMed ID
36866270
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
© 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).Attribution-NonCommercial-NoDerivatives 4.0 International